Human genetic basis of interindividual variability in the course of infection

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 51, 2015, Pages E7118-E7127

  Casanova, Jean Laurent ^a,b,c,d  

^a ROCKEFELLER UNIVERSITY   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d IMAGINE INSTITUTE   (France)

Author keywords

Human genetics; Immunology; Infectious diseases; Pediatrics; Primary immunodeficiency

Indexed keywords

ANTIFUNGAL AGENT; ANTIPARASITIC AGENT; ANTIVIRUS AGENT; QUININE; SULFANILAMIDE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; EUKARYOTE; GENETIC VARIABILITY; GERM THEORY OF DISEASE; HUMAN; HUMAN GENETICS; IMMUNE DEFICIENCY; IMMUNITY; IMMUNOLOGIST; IMMUNOLOGY; INFECTION; MALARIA; NONHUMAN; PALEOLITHIC; PLAGUE; PRIMARY INFECTION; PRIORITY JOURNAL; SICKLE CELL TRAIT; ANIMAL; BIOLOGICAL MODEL; ECOSYSTEM; GENETIC PREDISPOSITION; GENETICS; HETEROZYGOTE; IMMUNOLOGIC DEFICIENCY SYNDROMES; MEDICAL GENETICS; MICROBIOLOGY; PLANT;

ANIMALS; CARRIER STATE; ECOSYSTEM; GENETIC PREDISPOSITION TO DISEASE; GENETICS, MEDICAL; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFECTION; MALARIA; MODELS, GENETIC; MODELS, IMMUNOLOGICAL; PLANTS; SICKLE CELL TRAIT;

EID: 84952683321     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1521644112     Document Type: Article

References (161)

1. Nicolle C (1933) Les infections inapparentes. Scientia, 181-271.
2. Nicolle C (1937) Destin des Maladies Infectieuses (Alcan, Paris), 3rd Ed.
3. Lichtenthaeler C (1987) Geschichte derMedizin: Die Reihenfolge ihrer Epochen-Bilder und die treibenden Kräfte ihrer Entwicklung: ein Lehrbuch für Studenten, Ärzte, Historiker, und geschichtlich Interessierte (Deutscher Ärzte-Verlag, Cologne, Germany) 4th Ed.
4. Gaudillière JP, Löwy I (2001) Heredity and Infection (Routledge, London).
5. Ackerknecht EH (1967) Medicine at the Paris Hospital, 1794-1848 (Johns Hopkins Univ Press, Baltimore).
6. Olmsted JMD, Olmsted EH (1952) Claude Bernard and the Experimental Method in Medicine (Abelard Schuman, New York).
7. Bernard C (1865) An Introduction to the Study of Experimental Medicine (Dover Publications, New York) trans Green HC.
8. Olmsted JMD (1944) François Magendie. Pioneer in Experimental Physiology and Scientific Medicine in 19th Century France (Schuman's, New York), 1st Ed.
9. Lesh JE (1984) Science and Medicine in France. The Emergence of Experimental Physiology, 1790-1855 (Harvard Univ Press, Cambridge, MA), 1st Ed.
10. Coleman W, Holmes FL (1988) The Investigative Enterprise. Experimental Physiology in Nineteenth-Century Medicine (Univ of California Press, Berkeley, CA).
11. Céline L-F (1924) The Life and Work of Semmelweis (Little, Brown, and Company, Boston); trans Parker RA (1937).
12. Hempel S (2013) John Snow. Lancet 381(9874):1269-1270.
13. Pasteur L (1870) Etudes sur la Maladie des Vers à Soie. La Pébrine et la Flacherie. (Gauthiers-Villars, Paris), 1st Ed.
14. Pasteur L (1922-1939) Oeuvres Complètes de Louis Pasteur, Réunies par Pasteur Vallery-Radot (Masson et Cie, Paris).
15. Koch R (1882) Die Aetiologie der Tuberkulose. Berl Klin Wochenschr 19:221-230.
16. Nocard E, Leclainche E (1896) Les Maladies Microbiennes des Animaux (Masson, Paris).
17. Garnham P (1977) Charles Nicolle and inapparent infections. Am J Trop Med Hyg 26(5):1101-1104.
18. Von Pirquet C (1907) Die Allergieprobe zur Diagnose der Tuberkulose im Kindersalter. Wien Med Wochenschr 57:1369.
19. Wagner R (1968) Clemens von Irquet: His Life and Work (Johns Hopkins Univ Press, Baltimore).
20. Widal GFI, Sicard A (1896) Recherches de la réaction agglutinante dans le sang et le sérum dessechés des typhiques et dans la sérosité des vésicatoires. Bull Mém Soc Méd Hôp Paris series 3(13):681-682.
21. Von Gruber M, Durham HE (1896) Eine neue Methode zur raschen Erkennung des Choleravibrio und des Typhusbacillus. Munch Med Wochenschr 43:285-286.
22. Opie EL, Aronson JD (1927) Tubercle bacilli in latent tuberculous lesions and in lung tissue without tuberculous lesions. Arch Pathol 4:1-21.
23. Lincoln EM (1954) The effect of antimicrobial therapy on the prognosis of primary tuberculosis in children. Am Rev Tuberc 69(5):682-689.
24. Cairns J (1997) Matters of Life and Death (Princeton Univ Press, Princeton, NJ).
25. Casanova JL, Abel L (2005) Inborn errors of immunity to infection: The rule rather than the exception. J Exp Med 202(2):197-201.
26. Burnet M, White DO (1972) Natural History of Infectious Diseases (Cambridge Univ Press, Cambridge, UK), 4th Ed.
27. Cooper MD (2010) A life of adventure in immunobiology. Annu Rev Immunol 28:1-19.
28. Guo P, et al. (2009) Dual nature of the adaptive immune system in lampreys. Nature 459(7248):796-801.
29. Hirano M, et al. (2013) Evolutionary implications of a third lymphocyte lineage in lampreys. Nature 501(7467):435-438.
30. Pancer Z, et al. (2004) Somatic diversification of variable lymphocyte receptors in the agnathan sea lamprey. Nature 430(6996):174-180.
31. McGhee G (2011) Convergent Evolution. Limited Forms Most Beautiful (MIT Press, Cambridge, MA).
32. Pasteur L (1922-1939) Maladies Virulentes, Virus-Vaccins, Prophylaxie de la Rage (Masson et Cie, Paris).
33. Pirofski LA, Casadevall A (2008) The damage-response framework of microbial pathogenesis and infectious diseases. Adv Exp Med Biol 635:135-146.
34. Nathan C (2015) From transient infection to chronic disease. Science 350(6257):161.
35. Rynda-Apple A, Robinson KM, Alcorn JF (2015) Influenza and bacterial superinfection: Illuminating the immunologic mechanisms of disease. Infect Immun 83(10):3764-3770.
36. Avota E, Gassert E, Schneider-Schaulies S (2010) Measles virus-induced immunosuppression: From effectors to mechanisms. Med Microbiol Immunol (Berl) 199(3):227-237.
37. Moir S, Chun TW, Fauci AS (2011) Pathogenic mechanisms of HIV disease. Annu Rev Pathol 6:223-248.
38. Jones KD, Berkley JA (2014) Severe acute malnutrition and infection. Paediatr Int Child Health 34(Suppl 1):S1-S29.
39. Rytter MJ, Kolte L, Briend A, Friis H, Christensen VB (2014) The immune system in children with malnutrition-a systematic review. PLoS One 9(8):e105017.
40. Lassi ZS, et al. (2014) Essential interventions for child health. Reprod Health 11(Suppl 1):S4.
41. Alcaïs A, Abel L, Casanova JL (2009) Human genetics of infectious diseases: Between proof of principle and paradigm. J Clin Invest 119(9):2506-2514.
42. Falkow S (1988) Molecular Koch's postulates applied to microbial pathogenicity. Rev Infect Dis 10(Suppl 2):S274-S276.
43. Webster LT (1939) Heredity in infectious disease. J Hered, 365-370.
44. Vidal SM, Malo D, Marquis JF, Gros P (2008) Forward genetic dissection of immunity to infection in the mouse. Annu Rev Immunol 26:81-132.
45. Lurie M (1941) Heredity, constitution and tuberculosis: An experimental study. Am Rev Tuberc 44(suppl):1-125.
46. Fox G, Orlova M, Schurr E (2015) Tuberculosis in newborns: The lessons of the "Lübeck disaster" (1929-1933). PLoS Pathog, in press.
47. Foster WD (1970) A History of Medical Bacteriology and Immunology (Heinemann, London).
48. Bovet D (1988) Une Chimie Qui Guérit. Histoire de la Découverte des Sulfamides (Payot, Paris).
49. Moberg CL, Cohn Z (1990) Launching the Antibiotic Era (The Rockefeller Univ Press, New York).
50. Kindt TJ, Capra JD (1984) The Antibody Enigma (Plenum Publishing Company Limited, New York).
51. Silverstein AM (2009) A History of Immunology (Academic, London), 2nd Ed.
52. Landsteiner K (1936) The Specificity of Serological Reactions (Dover Publications, Inc., New York).
53. Cooper MD, Peterson RD, Good RA (1965) Delineation of the thymic and bursal lymphoid systems in the chicken. Nature 205:143-146.
54. Cooper MD, Raymond DA, Peterson RD, South MA, Good RA (1966) The functions of the thymus system and the bursa system in the chicken. J Exp Med 123(1):75-102.
55. Cooper MD (2015) The early history of B cells. Nat Rev Immunol 15(3):191-197.
56. Miller JF (1961) Immunological function of the thymus. Lancet 2(7205):748-749.
57. Miller JF (1961) Analysis of the thymus influence in leukaemogenesis. Nature 191:248-249.
58. Miller JF (2011) The golden anniversary of the thymus. Nat Rev Immunol 11(7):489-495.
59. Soderqvist T (2003) Science as Autobiography: The Troubled Life of Niels Jerne (Yale Univ Press, New Haven, CT).
60. Beutler B (2003) Not "molecular patterns" but molecules. Immunity 19(2):155-156.
61. Beutler B (2004) Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430(6996):257-263.
62. Lemaitre B (2004) The road to Toll. Nat Rev Immunol 4(7):521-527.
63. Lemaitre B, Hoffmann J (2007) The host defense of Drosophila melanogaster. Annu Rev Immunol 25:697-743.
64. Janeway CA, Jr, Medzhitov R (2002) Innate immune recognition. Annu Rev Immunol 20:197-216.
65. Takeda K, Kaisho T, Akira S (2003) Toll-like receptors. Annu Rev Immunol 21:335-376.
66. Fearon DT, Locksley RM (1996) The instructive role of innate immunity in the acquired immune response. Science 272(5258):50-53.
67. De Kruif P (1926) Microbe Hunters (Blue Ribbons Books, New York), 1 Ed.
68. Casadevall A, Pirofski LA (2014) Microbiology: Ditch the term pathogen. Nature 516(7530):165-166.
69. Mayr E (1988) Toward a New Philosophy of Biology (Harvard Univ Press, Cambridge, MA).
70. Ayala FJ, Dobzhansky T (1974) Studies in the Philosophy of Biology (Univ of California Press, Berkeley, CA).
71. Papermaster BW, Condie RM, Finstad JK, Good RA, Gabrielsen AE (1963) Phylogenetic development of adaptive immunity. Fed Proc 22:1152-1155.
72. Mazumdar PMH (1995) Species and Specificity. An Interpretation of the History of Immunology (Cambridge Univ Press, Cambridge, UK).
73. Besredka A (1921) Histoire d'une Idée. L'oeuvre de Metchnikoff (Masson & Cie, Paris).
74. Dubos RJ (1955) Second thoughts on the germ theory. Sci Am 192:31-35.
75. Dubos RJ (1950) Louis Pasteur, Free Lance of Science (Little Brown, Boston), 1st Ed.
76. Moberg CL (2005) René Dubos. Friend of the Good Earth. Microbiologist, Medical Scientist, Environmentalist (ASM, Washington, D. C.).
77. Tompkins DM, Dunn AM, Smith MJ, Telfer S (2011) Wildlife diseases: From individuals to ecosystems. J Anim Ecol 80(1):19-38.
78. Dubos R (1966) The microbiota of the gastrointestinal tract. Gastroenterology 51(5):868-874.
79. Lee A, Gordon J, Lee CJ, Dubos R (1971) The mouse intestinal microflora with emphasis on the strict anaerobes. J Exp Med 133(2):339-352.
80. Biffen RH (1905) Mendel's laws of inheritance and wheat breeding. J Agric Sci 1(1):4-48.
81. Flor HH (1971) Current status of the gene-for-gene concept. Annu Rev Phytopathol 9:275-296.
82. Dangl JL, Horvath DM, Staskawicz BJ (2013) Pivoting the plant immune system from dissection to deployment. Science 341(6147):746-751.
83. Flor HH (1942) Inheritance of pathogenicity in a cross between physiologic races 22 and 24 of Melampsora lini. Phytopathology 32:5.
84. Flor HH (1955) Host-parasite interaction in flax rust - its genetics and other implications. Phytopathology 45:680-685.
85. Martin GB, et al. (1993) Map-based cloning of a protein kinase gene conferring disease resistance in tomato. Science 262(5138):1432-1436.
86. Grant MR, et al. (1995) Structure of the Arabidopsis RPM1 gene enabling dual specificity disease resistance. Science 269(5225):843-846.
87. Staskawicz BJ, Ausubel FM, Baker BJ, Ellis JG, Jones JD (1995) Molecular genetics of plant disease resistance. Science 268(5211):661-667.
88. Casanova JL, Schurr E, Abel L, Skamene E (2002) Forward genetics of infectious diseases: Immunological impact. Trends Immunol 23(10):469-472.
89. Shultz LD, Sidman CL (1987) Genetically determined murine models of immunodeficiency. Annu Rev Immunol 5:367-403.
90. Skamene E, Kongshawn PAL, Landy M (1980) Genetic Control of Natural Resistance to Infection and Malignancy (Academic, New York).
91. Rosenstreich DL, Weinblatt AC, O'Brien AD (1982) Genetic control of resistance to infection in mice. Crit Rev Immunol 3(4):263-330.
92. Searle AG (1959) Hereditary absence of spleen in the mouse. Nature 184(Suppl 18):1419-1420.
93. Lindenmann J (1964) Inheritance of resistance to influenza virus in mice. Proc Soc Exp Biol Med 116:506-509.
94. Staeheli P, Haller O, Boll W, Lindenmann J, Weissmann C (1986) Mx protein: Constitutive expression in 3T3 cells transformed with cloned Mx cDNA confers selective resistance to influenza virus. Cell 44(1):147-158.
95. Skamene E, et al. (1982) Genetic regulation of resistance to intracellular pathogens. Nature 297(5866):506-509.
96. Vidal SM, Malo D, Vogan K, Skamene E, Gros P (1993) Natural resistance to infection with intracellular parasites: Isolation of a candidate for Bcg. Cell 73(3):469-485.
97. Poltorak A, et al. (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 282(5396):2085-2088.
98. Brown MG, et al. (2001) Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 292(5518):934-937.
99. Garrod AE (1931) The Inborn Factors in Disease (Clarendon, Oxford).
100. Pearson K (1912) Tuberculosis, Heredity and Environment (Dulau and Co., Ltd., London).
101. Fernández-Cañón JM, et al. (1996) The molecular basis of alkaptonuria. Nat Genet 14(1):19-24.
102. Garrod AE (1902) The incidence of alkaptonuria: A study in clinical individuality. Lancet 2:1616-1620.
103. Pearson ES (1938) Karl Peason, an Appreciation of Some Aspects of His Life and Work (Cambridge Univ Press, Cambridge, UK).
104. Flavia SM (1940) A family pedigree of appendicitis. J Hered, 113-115.
105. Puffer R (1944) Familial Susceptibility to Tuberculosis; Its Importance as a Public Health Problem (Harvard Univ Press, Cambridge, MA).
106. Kallmann F, Reisner D (1943) Twin studies on the significance of genetic factors in tuberculosis. Am Rev Tuberc 47:549-574.
107. Sørensen TI, Nielsen GG, Andersen PK, Teasdale TW (1988) Genetic and environmental influences on premature death in adult adoptees. N Engl J Med 318(12):727-732.
108. Casanova JL, Abel L (2013) The genetic theory of infectious diseases: A brief history and selected illustrations. Annu Rev Genomics Hum Genet 14:215-243.
109. Etzioni A, Ochs H (2014) Primary Immunodeficiency Disorders. A Historic and Scientific Perspective (Academic, Oxford).
110. Bruton OC (1952) Agammaglobulinemia. Pediatrics 9(6):722-728.
111. Bruton OC (1962) A decade with agammaglobulinemia. J Pediatr 60:672-676.
112. Cooper MD, et al. (1973) Classification of primary immunodeficiencies. N Engl J Med 288(18):966-967.
113. Fudenberg HH, et al. (1970) Classification of the primary immune deficiencies: WHO recommendation. N Engl J Med 283(12):656-657.
114. Armstrong D (1993) History of opportunistic infection in the immunocompromised host. Clin Infect Dis 17(Suppl 2):S318-S321.
115. Donaldson VH, Evans RR (1963) A biochemical abnormality in herediatry angioneurotic edema: Absence of serum inhibitor of C' 1-esterase. Am J Med 35:37-44.
116. Hirschhorn R, et al. (1996) Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency. Nat Genet 13(3):290-295.
117. Devriendt K, et al. (2001) Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia. Nat Genet 27(3):313-317.
118. Gatti RA, Meuwissen HJ, Allen HD, Hong R, Good RA (1968) Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet 2(7583):1366-1369.
119. Cavazzana-Calvo M, et al. (2000) Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288(5466):669-672.
120. Al-Herz W, et al. (2014) Primary immunodeficiency diseases: An update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol 5:162.
121. Bousfiha AA, et al. (2013) A phenotypic approach for IUIS PID classification and diagnosis: Guidelines for clinicians at the bedside. J Clin Immunol 33(6):1078-1087.
122. Zhang Y, Su HC, Lenardo MJ (2015) Genomics is rapidly advancing precision medicine for immunological disorders. Nat Immunol 16(10):1001-1004.
123. Milner JD, Holland SM (2013) The cup runneth over: Lessons from the ever-expanding pool of primary immunodeficiency diseases. Nat Rev Immunol 13(9):635-648.
124. Pessach I, Walter J, Notarangelo LD (2009) Recent advances in primary immunodeficiencies: Identification of novel genetic defects and unanticipated phenotypes. Pediatr Res 65(5 Pt 2):3R-12R.
125. Crow YJ (2015) Type I interferonopathies: Mendelian type I interferon up-regulation. Curr Opin Immunol 32:7-12.
126. Masters SL, Simon A, Aksentijevich I, Kastner DL (2009) Horror autoinflammaticus: The molecular pathophysiology of autoinflammatory disease. Annu Rev Immunol 27:621-668.
127. Williams KW, Milner JD, Freeman AF (2015) Eosinophilia Associated with Disorders of Immune Deficiency or Immune Dysregulation. Immunol Allergy Clin North Am 35(3):523-544.
128. Bonthron DT, Markham AF, Ginsburg D, Orkin SH (1985) Identification of a point mutation in the adenosine deaminase gene responsible for immunodeficiency. J Clin Invest 76(2):894-897.
129. Royer-Pokora B, et al. (1986) Cloning the gene for an inherited human disorder-chronic granulomatous disease-on the basis of its chromosomal location. Nature 322(6074):32-38.
130. Bolze A, et al. (2010) Whole-exome-sequencing-based discovery of human FADD deficiency. Am J Hum Genet 87(6):873-881.
131. Pauling L, et al. (1949) Sickle cell anemia a molecular disease. Science 110(2865):543-548.
132. Gilligan PH (1991) Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiol Rev 4(1):35-51.
133. Booth C, Inusa B, Obaro SK (2010) Infection in sickle cell disease: A review. Int J Infect Dis 14(1):e2-e12.
134. Alcaïs A, et al. (2010) Life-threatening infectious diseases of childhood: Single-gene inborn errors of immunity? Ann NYAcad Sci 1214(1):18-33.
135. Allison AC (1954) Protection afforded by sickle-cell trait against subtertian malareal infection. BMJ 1(4857):290-294.
136. Allison AC (2009) Genetic control of innate immunity to malaria. Curr Opin Immunol 21(5):499-505.
137. Dobzhansky T (1962) Mankind Evolving (Yale Univ Press, New Haven, CT).
138. Abel L, Alcaïs A, Schurr E (2014) The dissection of complex susceptibility to infectious disease: Bacterial, viral and parasitic infections. Curr Opin Immunol 30:72-78.
139. Bearn AG (1993) Archibald Garrod and the Individuality of Man (Clarendon Press, Oxford, UK).
140. Wang AT, Smogorzewska A (2015) SnapShot: Fanconi anemia and associated proteins. Cell 160(1-2):354.
141. Kwiatkowski DP (2005) How malaria has affected the human genome and what human genetics can teach us about malaria. Am J Hum Genet 77(2):171-192.
142. Abel L, Demenais F (1988) Detection of major genes for susceptibility to leprosy and its subtypes in a Caribbean island: Desirade Island. Am J Hum Genet 42(2):256-266.
143. Abel L, Demenais F, Prata A, Souza AE, Dessein A (1991) Evidence for the segregation of a major gene in human susceptibility/resistance to infection by Schistosoma mansoni. Am J Hum Genet 48(5):959-970.
144. Abel L, Cot M, Mulder L, Carnevale P, Feingold J (1992) Segregation analysis detects a major gene controlling blood infection levels in human malaria. Am J Hum Genet 50(6):1308-1317.
145. Abel L, et al. (1995) Complex segregation analysis of leprosy in southern Vietnam. Genet Epidemiol 12(1):63-82.
146. Alcaïs A, et al. (1997) Evidence for a major gene controlling susceptibility to tegumentary leishmaniasis in a recently exposed Bolivian population. Am J Hum Genet 61(4):968-979.
147. Cobat A, et al. (2009) Two loci control tuberculin skin test reactivity in an area hyperendemic for tuberculosis. J Exp Med 206(12):2583-2591.
148. Mira MT, et al. (2004) Susceptibility to leprosy is associated with PARK2 and PACRG. Nature 427(6975):636-640.
149. Casanova JL, Abel L (2007) Human genetics of infectious diseases: A unified theory. EMBO J 26(4):915-922.
150. Baghdadi JE, et al. (2006) An autosomal dominant major gene confers predisposition to pulmonary tuberculosis in adults. J Exp Med 203(7):1679-1684.
151. Alcaïs A, et al. (2007) Stepwise replication identifies a low-producing lymphotoxinalpha allele as a major risk factor for early-onset leprosy. Nat Genet 39(4):517-522.
152. Bucheton B, et al. (2003) A major susceptibility locus on chromosome 22q12 plays a critical role in the control of kala-azar. Am J Hum Genet 73(5):1052-1060.
153. Dessein AJ, et al. (1999) Severe hepatic fibrosis in Schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferon-gamma receptor gene. Am J Hum Genet 65(3):709-721.
154. Marquet S, et al. (1996) Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Nat Genet 14(2):181-184.
155. Ge D, et al. (2009) Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461(7262):399-401.
156. Thomas DL, et al. (2009) Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461(7265):798-801.
157. Genovese G, et al. (2010) Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329(5993):841-845.
158. Pays E, Vanhollebeke B, Uzureau P, Lecordier L, Pérez-Morga D (2014) Themolecular arms race between African trypanosomes and humans. Nat Rev Microbiol 12(8):575-584.
159. McLaren PJ, Carrington M (2015) The impact of host genetic variation on infection with HIV-1. Nat Immunol 16(6):577-583.
160. Walker BD, Yu XG (2013) Unravelling the mechanisms of durable control of HIV-1. Nat Rev Immunol 13(7):487-498.
161. Casanova J-L (2015) Severe infectious diseases of childhood as monogenic inborn errors of immunity. Proc Natl Acad Sci USA 112:E7128-E7137.